Adaptive Biotechnologies (FRA:1HM) Purchase Of Property, Plant, Equipment : €-8.6 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Adaptive Biotechnologies Purchase Of Property, Plant, Equipment?

Adaptive Biotechnologies's purchase of property, plant, equipment for the three months ended in Mar. 2024 was €-1.4 Mil. It means Adaptive Biotechnologies spent €1.4 Mil on purchasing property, plant, equipment. Adaptive Biotechnologies's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Mar. 2024 was €-8.6Mil.

Compared with last quarter (€-1.2 Mil in Dec. 2023 ), Adaptive Biotechnologies spent more money on purchasing property, plant, equipment in Mar. 2024 (€-1.4 Mil).

Adaptive Biotechnologies Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Adaptive Biotechnologies's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adaptive Biotechnologies Purchase Of Property, Plant, Equipment Chart

Adaptive Biotechnologies Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Property, Plant, Equipment

Get a 7-Day Free Trial

-10.08

-15.46

-54.65

-15.43

-9.81

Adaptive Biotechnologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Purchase Of Property, Plant, Equipment	Get a 7-Day Free Trial															-2.73	-3.41	-2.60	-1.19	-1.39

Adaptive Biotechnologies Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-8.6 Mil.

Adaptive Biotechnologies Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Adaptive Biotechnologies's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Adaptive Biotechnologies (FRA:1HM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adaptive Biotechnologies Corp (FRA:1HM) » Definitions » Purchase Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

ADPT:USA 1HM:Germany

Address

1165 Eastlake Avenue East, Seattle, WA, USA, 98109

Website

https://www.adaptivebiotech.com

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease ("MRD") in patients with multiple myeloma ("MM"), B cell acute lymphoblastic leukemia ("ALL") and chronic lymphocytic leukemia ("CLL") and is also available as a CLIA-validated laboratory developed test ("LDT") for patients with other lymphoid cancers, including diffuse large B-cell lymphoma ("DLBCL").

Adaptive Biotechnologies (FRA:1HM) Headlines

No Headlines